Peptide drugs in a reusable pen

A reusable pen device with a replaceable cartridge and dose selection mechanism addresses the need for affordable and convenient peptide drug delivery, providing continuous treatment with variable dose options and improving patient satisfaction.

WO2026139792A1PCT designated stage Publication Date: 2026-07-02BIOCON LTD

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
BIOCON LTD
Filing Date
2025-12-18
Publication Date
2026-07-02

AI Technical Summary

Technical Problem

There is a gap in understanding patient preferences for reusable versus disposable pens for peptide drug delivery, particularly in emerging countries, and existing technologies do not effectively address the need for affordable and convenient delivery systems.

Method used

A reusable pen device with a replaceable cartridge holder assembly, dose selection mechanism, and dose delivery mechanism is provided for administering peptide drugs like liraglutide, semaglutide, tirzepatide, and others, allowing variable or fixed dose settings and single-use needle delivery.

Benefits of technology

The reusable pen device offers cost-effective, continuous drug delivery with variable dose options, addressing patient preferences and affordability, particularly in emerging markets, while maintaining treatment efficacy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IMGF000014_0001_TABLE
    Figure IMGF000014_0001_TABLE
  • Figure IMGF000015_0001_TABLE
    Figure IMGF000015_0001_TABLE
  • Figure IMGF000017_0001_TABLE
    Figure IMGF000017_0001_TABLE
Patent Text Reader

Abstract

The present invention relates to a method for administration of peptide drugs via a reusable pen comprising a replaceable drug cartridge. In particular, the present invention relates to a liraglutide solution administered via a reusable pen. Further, the present invention relates to a semaglutide solution administered via a reusable pen. Further, the present invention also relates to a tirzepatide solution administered via a reusable pen. Further, the present invention also relates to a setmelanotide solution administered via a reusable pen. Further, the present invention also relates to a teduglutide solution administered via a reusable pen.
Need to check novelty before this filing date? Find Prior Art